These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4394680)

  • 1. The effect of antilymphocyte serum on graft-versus-host reactivity.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):391-6. PubMed ID: 4394680
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood plasma alpha globulin fraction and antilymphocytic serum administered to mice. Effect on host reaction to graft and graft reaction to host (author's transl)].
    Cajthamlová H; Bednarík T
    Cas Lek Cesk; 1978 Apr; 117(15):463-6. PubMed ID: 77732
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of a heterologous, cutaneous Graft-Versus-Host reaction in mice].
    Brune K
    Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):74-88. PubMed ID: 4391808
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic resistance in the graft-versus-host reaction.
    Sula K; Nouza K
    Exp Clin Immunogenet; 1984; 1(3):175-84. PubMed ID: 6101099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of a heterologous, cutaneous graft-versus-host reaction in mice. II. Reactivity of graft and host].
    Brune K; Bucher KE
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(2):73-86. PubMed ID: 4400329
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

  • 10. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
    Trentin JJ; Judd KP
    Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
    [No Abstract]   [Full Text] [Related]  

  • 12. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
    Hilgert I; Nouza K
    Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-versus-host reactivity and inhibitory serum factors in allograft-tolerant chickens.
    Droege W; Mayor K
    Transplantation; 1975 Jun; 19(6):517-20. PubMed ID: 237355
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration in graft vs host reactivity and in hematopoietic stem cells of spleen cell inocula from donor mice pretreated with pertussis antigen.
    Eikman EA; Bowser RT
    J Immunol; 1972 Jan; 108(1):253-60. PubMed ID: 4400863
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in graft--ersus-host reactivity and peripheral leukocytes in mice after erythropoietin treatment.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1975 Aug; 3(4):234-43. PubMed ID: 240732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
    Jeannet M; Vaucher A; Gervasoni C
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
    Nehlsen SL
    Clin Exp Immunol; 1971 Jul; 9(1):63-77. PubMed ID: 4397709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of a nonprotein spleen factor on the course of delayed-type hypersensitivity and graft versus host reactions].
    Bykova LM; Synel'nykova HL; Oliĭnyk BV
    Fiziol Zh (1994); 2001; 47(5):74-6. PubMed ID: 11758472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.